Close



Mar 6, 2024 04:31PM
Mar 6, 2024 04:31PM
Feb 21, 2024 07:03AM
Feb 21, 2024 07:00AM
Nov 28, 2023 06:59AM
Nov 8, 2023 05:38PM
Aug 8, 2023 04:31PM Emergent BioSolutions Reports Financial Results for Second Quarter 2023
May 15, 2023 07:36AM
May 9, 2023 04:05PM
Mar 29, 2023 01:58PM
Feb 27, 2023 04:42PM
Feb 27, 2023 04:42PM
Feb 15, 2023 06:00AM
Feb 15, 2023 02:00AM Bavarian Nordic to Acquire Portfolio of Travel Vaccines from Emergent BioSolutions
Feb 15, 2023 02:00AM
Feb 15, 2023 02:00AM
Jan 9, 2023 06:59AM
Jan 9, 2023 06:59AM
Jan 9, 2023 06:59AM
Nov 14, 2022 06:31AM
Nov 14, 2022 06:30AM Emergent BioSolutions Receives Department of Defense Award to Evaluate Chikungunya Vaccine Candidate in Post-Approval Field Efficacy Study Using Model-Guided Approach
Nov 14, 2022 06:30AM
Nov 8, 2022 04:16PM
Nov 8, 2022 04:16PM
Sep 26, 2022 04:12PM
Sep 26, 2022 04:12PM
Aug 1, 2022 04:05PM
Aug 1, 2022 04:05PM Emergent BioSolutions Reports Financial Results for Second Quarter 2022
May 16, 2022 09:25AM
May 16, 2022 06:33AM
May 16, 2022 06:32AM
May 16, 2022 06:32AM
Apr 28, 2022 04:05PM
Apr 28, 2022 04:05PM
Feb 24, 2022 04:05PM Emergent BioSolutions Reports Financial Results for Fourth Quarter 2021
Jan 14, 2022 06:31AM
Jan 14, 2022 06:30AM
Jan 14, 2022 06:30AM
Jan 10, 2022 05:52AM
Jan 9, 2022 02:00PM
Jan 9, 2022 02:00PM
Nov 4, 2021 04:05PM Emergent BioSolutions Reports Financial Results For Third Quarter 2021
Nov 4, 2021 04:05PM
Nov 2, 2021 09:00PM
Nov 2, 2021 09:00AM
Jul 29, 2021 04:05PM
Jul 29, 2021 04:05PM
Jun 2, 2021 09:00PM
May 26, 2021 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Arcimoto, Churchill, Emergent BioSolutions, and Verus International and Encourages Investors to Contact
May 24, 2021 11:10PM

924,308 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All